Caplin Point Laboratories

BSE : 524742 | NSE : CAPLIPOINT

Industry : Pharma Formulations | ISIN : INE475E01026 | FreeFloat : 30.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)2,585.83
Net Worth (NW)848.91
Intrinsic Worth (IW)3,434.74
Market Cap (MC)2,275.71
Economic Value Added26.44
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)75.28%
IC Gross Margin (EBITDA/IC)12.34%
IC Net Margin (NPT/IC)9.07%
Knowledge Turnover (Sales/IC)0.34
Market to Intrinsic Value (MC/IW)0.66

As OfIntrinsic ValueMarket Price
31 Dec 2019Rs. 454.07Rs. 300.85
29 May 2020 - Rs. 320.20
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 319.74BuyStrong Buy
KB > 50% : Yes50 DMA : Rs. 301.68
0 < M2IV < 1 : YesVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-17
C
120.52
122.33
45.82
40.83
42.61
33.30
33.41
Jun-17
C
123.51
127.37
45.89
42.05
45.90
36.32
36.33
Sep-17
C
131.31
134.89
49.36
44.91
48.47
35.54
35.57
Dec-17
C
141.61
143.94
50.78
46.26
48.58
37.48
37.48
Mar-18
C
143.41
146.31
51.62
45.44
45.43
35.29
35.94
Jun-18
C
146.46
148.07
54.64
49.19
49.17
37.39
37.43
Sep-18
C
155.86
162.88
62.80
57.22
57.20
43.50
46.81
Dec-18
C
159.03
166.77
65.50
59.82
59.81
45.81
46.53
Mar-19
C
187.34
190.01
67.43
60.71
60.69
49.86
45.53
Jun-19
C
192.55
197.02
71.94
64.55
64.45
50.07
49.70
Sep-19
C
227.20
234.10
78.01
70.60
70.52
57.27
61.79
Dec-19
C
228.21
238.55
78.11
69.68
69.62
58.84
60.10
* C - Consolidated, S - Standalone